Related MeSH Hierarchy (7)
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Nervous System Neoplasms » Peripheral Nervous System Neoplasms » Cranial Nerve Neoplasms » Optic Nerve Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Optic Nerve Diseases » Optic Nerve Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Nervous System Neoplasms » Cranial Nerve Neoplasms » Optic Nerve Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Nervous System Neoplasms » Peripheral Nervous System Neoplasms » Cranial Nerve Neoplasms » Optic Nerve Neoplasms
Diseases [C] » Eye Diseases [C11] » Optic Nerve Diseases » Optic Nerve Neoplasms
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Nervous System Neoplasms » Cranial Nerve Neoplasms » Optic Nerve Neoplasms
Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Cranial Nerve Neoplasms » Optic Nerve Neoplasms
Description
Benign and malignant neoplasms that arise from the optic nerve or its sheath. OPTIC NERVE GLIOMA is the most common histologic type. Optic nerve neoplasms tend to cause unilateral visual loss and an afferent pupillary defect and may spread via neural pathways to the brain. MeSH
Hierarchy View
Subtype Terms (1)
Optic Nerve Glioma
12 drugs (9 approved, 3 experimental)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
